Charles River Laboratories (CRL) Tops Q2 EPS by 9c; Guides Higher
Charles River Laboratories (NYSE: CRL) reported Q2 EPS of $0.75, $0.09 better than the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
